6505-33-104-0817

Clindamycin Hydrochloride Capsules

6505331040817 331040817 DALACIN 30 MG 500 CAPSULAS CLINWAS 300 MG 500 CAPSULAS 640268 8470006402689 8470006451687 J01FF01

Managed by Spain

NSN Created on 27 Apr 1995

Data Last Changed
January 2023

NATO Update Count
1

NATO Data Quality

6505-33-104-0817 CLINDAMYCIN HYDROCHLORIDE CAPSULES 6505331040817 331040817 1/1 — NSN 6505-33-104-0817 (Generic Image) 1/1

Marketplace 6505-33-104-0817

Need Help?
Request a Quotation from participating marketplace vendors

Updated Every Day

6505-33-104-0817 RQST NE

Updated Every Day

6505-33-104-0817 RQST

Updated Every Day

6505-33-104-0817 RQST NE

Related Documents 6505-33-104-0817 5+ Documents (More...)

https//www.nsnlookup.com
/fsg-65/fsc-6505/be

6505-13-119-4131 Clindamycin Hydrochloride Capsules 131194131

Hydrochloride For Oral Suspension6505131204156 131204156 DALACIN C SIR 80 ML - 75MG/5 ML 0030916 J01FF01
Clindamycin Hydrochloride Capsules 331040817 331040817 DALACIN 30 MG 500 CAPSULAS CLINWAS 300 MG
500 CAPSULAS 640268 8470006402689 8470006451687 J01FF01 Documents 6505-33-104-0817 5+ Documents ( More

https//www.nsnlookup.com
/fsg-65/fsc-6505/es

6505-33-190-1702 Clindamycin Hydrochloride Capsules 331901702

Documents 6505-33-190-1702 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/es 6505-33-104-0817
Clindamycin Hydrochloride Capsules 331040817 0033670 J01FF01 Capsules 190005103 RNVC 1 DAC 3 NATO
Hydrochloride Capsules 190005103 Stock Numbers Related to 6505-19-000-5103 6505-33-190-1702 6505-33-104-0817

https//www.nsnlookup.com
/fsg-65/fsc-6505/be

6505-13-116-2664 Clindamycin Hydrochloride Capsules 131162664

Hydrochloride Capsules Hydrochloride Capsules 131162664 https//www.nsnlookup.com /fsg-65/fsc-6505/es 6505-33-104-0817
Clindamycin Hydrochloride Capsules 331040817 DAC 3 NATO Stock Numbers Related to 6505-19-000-5103
6505-33-190-1702 6505-33-104-0817 Capsules 131162664 RNVC 2 DAC 2 NATO Stock Numbers Related to 6505

https//www.nsnlookup.com
/fsg-65/fsc-6505/uk

6505-99-211-4300 Clindamycin Hydrochloride Capsules 992114300

Capsules 190006109 Hydrochloride Capsules 695-8165 6505-01-680-0696 6505-99-211-4300 190-1702 6505-33-104-0817
4892 Usp Clindamycin Hydrochloride Capsules 695-8165 6505-01-680-0696 6505-99-211-4300 190-1702 6505-33-104-0817
Hydrochloride Capsules 190006109 Capsules 695-8165 6505-01-680-0696 6505-99-211-4300 190-1702 6505-33-104-0817

https//www.nsnlookup.com
/fsg-65/fsc-6505/us

6505-01-680-0696 Clindamycin Hydrochloride Capsules 016800696

4892 Usp Clindamycin Hydrochloride Capsules 695-8165 6505-01-680-0696 000-5103 6505-33-190-1702 6505-33-104-0817
Capsules 190006109 Hydrochloride Capsules 695-8165 6505-01-680-0696 119-4131 6505-33-190-1702 6505-33-104-0817
Hydrochloride Capsules 190006109 Capsules 695-8165 6505-01-680-0696 001-3031 6505-33-190-1702 6505-33-104-0817

Restrictions 6505-33-104-0817

6505-33-104-0817 is a Clindamycin Hydrochloride Capsules

Approved Sources 6505-33-104-0817

Part Number
Manufacturer
Status
640268: 7080B - Upjohn Farmoquimica S.A. (Obsolete); Primary Buy; RNCC 3 RNVC 2 DAC 3
DALACIN 30 MG 500 CAPSULAS: 7080B - Upjohn Farmoquimica S.A. (Obsolete); Incomplete Secondary Reference; RNCC 5 RNVC 1 DAC 3
CLINWAS 300 MG 500 CAPSULAS: 7113B - Chiesi Espana Sa (Active); Incomplete Secondary Reference; RNCC 5 RNVC 1 DAC 3
8470006402689: 7080B - Upjohn Farmoquimica S.A. (Obsolete); Secondary Buy; RNCC 5 RNVC 2 DAC U
8470006451687: 7113B - Chiesi Espana Sa (Active); Secondary Buy; RNCC 5 RNVC 2 DAC U
J01FF01: I9022 - Who Collaborating Centre For Drug (Active); NATO Reference; RNCC 6 RNVC 9 DAC 9

NATO Stock Numbers Related to 6505-33-104-0817

6505-33-190-1702 6505-33-104-0817 6505-13-119-4131 6505-19-001-3031 6505-01-695-8165 6505-01-680-0696 6505-99-211-4300 6505-19-000-6109 6505-33-005-2496 6505-00-118-1794 6505-19-000-5103 6505-33-189-9452 6505-01-290-4628 6505-01-292-5617 6505-21-909-0941 6505-13-116-2664 6505-00-159-4892